Literature DB >> 21779968

Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.

Jennifer Mason1, Munir Pirmohamed, Tony Nunn.   

Abstract

The use of unlicensed and off-label medicines in children is common because trials in children have not usually been performed during the drug development process. Consequently, the information available to paediatricians may not always be as detailed or as robust as that available when prescribing a medicine that is licensed for an approved indication. This has led to concerns that children may be receiving drugs at dosages that either lack efficacy or present safety problems. The latter in particular has received a great deal of attention. In this narrative review, we have evaluated the use of off-label and unlicensed medicines in children and whether and how frequently this predisposes to adverse drug reactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21779968     DOI: 10.1007/s00228-011-1097-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Reported adverse drug reactions and their determinants in Dutch children outside the hospital.

Authors:  Eric Schirm; Hilde Tobi; Eugène P van Puijenbroek; Margje H Monster-Simons; Lolkje T W de Jong-van den Berg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-03       Impact factor: 2.890

2.  Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study.

Authors:  A P Jonville-Béra; F Béra; E Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2005-04-12       Impact factor: 2.953

3.  Drug related problems and off-label drug treatment in children as seen at a drug information centre.

Authors:  Elin Kimland; Ulf Bergman; Synnöve Lindemalm; Ylva Böttiger
Journal:  Eur J Pediatr       Date:  2006-12-29       Impact factor: 3.183

Review 4.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

5.  Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

6.  Determinants for drug prescribing to children below the minimum licensed age.

Authors:  Geert W 't Jong; Ingo A Eland; Miriam C J M Sturkenboom; John N van den Anker; Bruno H C Stricker
Journal:  Eur J Clin Pharmacol       Date:  2003-02-06       Impact factor: 2.953

7.  Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors:  S Turner; A J Nunn; K Fielding; I Choonara
Journal:  Acta Paediatr       Date:  1999-09       Impact factor: 2.299

8.  Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden.

Authors:  Mike Ufer; Elin Kimland; Ulf Bergman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-03       Impact factor: 2.890

9.  The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.

Authors:  Antje Neubert; Harald Dormann; Jutta Weiss; Tobias Egger; Manfred Criegee-Rieck; Wolfgang Rascher; Kay Brune; Burkhard Hinz
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

10.  Adverse drug reactions in a paediatric intensive care unit.

Authors:  A M Gill; H J Leach; J Hughes; C Barker; A J Nunn; I Choonara
Journal:  Acta Paediatr       Date:  1995-04       Impact factor: 2.299

View more
  30 in total

1.  Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.

Authors:  Laura Cuzzolin; Rocco Agostino
Journal:  Eur J Clin Pharmacol       Date:  2016-01       Impact factor: 2.953

2.  A survey of medicine use in children and adolescents in Austria.

Authors:  Elisabeth Rauch; Florian B Lagler; Harald Herkner; Walter Gall; Robert Sauermann; Silvia Hetz; Christoph Male
Journal:  Eur J Pediatr       Date:  2018-07-05       Impact factor: 3.183

3.  Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.

Authors:  Arton Baftiu; Cecilie Johannessen Landmark; Ida Rudberg Rusten; Silje Andrea Feet; Svein I Johannessen; Pål G Larsson
Journal:  Eur J Clin Pharmacol       Date:  2016-07-13       Impact factor: 2.953

Review 4.  The evidence-based choice for antipsychotics in children and adolescents should be guaranteed.

Authors:  Daria Putignano; Antonio Clavenna; Laura Reale; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2019-02-07       Impact factor: 2.953

5.  Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.

Authors:  Nurul Fadilah Mohamad; Adliah Mhd Ali; Noraida Mohamed Shah
Journal:  Int J Clin Pharm       Date:  2014-12-09

6.  Retapamulin prescriptions and monitored off-label use.

Authors:  Linda M Mundy; Tim Sampson; John W Logie
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

7.  Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy.

Authors:  Davide Zanon; Luca Gallelli; Francesca Rovere; Rossella Paparazzo; Natalia Maximova; Marzia Lazzerini; Antonio Reale; Tiziana Corsetti; Salvatore Renna; Tullia Emanueli; Francesco Mannelli; Francesco Manteghetti; Liviana Da Dalt; Caterina Palleria; Nicola Banchieri; Antonio Urbino; Mario Miglietta; Giovanni Cardoni; Adriana Pompilio; Alberto Arrighini; Clara Lazzari; Gianni Messi
Journal:  Eur J Pediatr       Date:  2012-12-04       Impact factor: 3.183

8.  Federal legislation and the advancement of neonatal drug studies.

Authors:  Jason R Wiles; Alexander A Vinks; Henry Akinbi
Journal:  J Pediatr       Date:  2012-10-27       Impact factor: 4.406

9.  Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

Authors:  Hui Li; Mark J Canet; John D Clarke; Dean Billheimer; Stavra A Xanthakos; Joel E Lavine; Robert P Erickson; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2017-10-06       Impact factor: 3.922

Review 10.  Postoperative Nausea and Vomiting in Pediatric Patients.

Authors:  Anthony L Kovac
Journal:  Paediatr Drugs       Date:  2020-10-27       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.